Tzivia compresses any corpus into a self-organizing knowledge graph and hands an AI agent back only what's relevant — in milliseconds, not another full re-read. Built as an MCP server: it plugs into Claude, Cursor, and any MCP-compatible host with no custom integration.
Every number on this page comes from a reproducible evaluation harness, not a demo cherry-picked to look good. LoCoMo results are below; LongMemEval is next.
Ingests any corpus — documents, conversations, research — and builds a multi-tier knowledge graph instead of a flat vector dump.
Bridges concepts across the graph through learned, weighted connections — the paths she uses most get faster over time, not just bigger.
Returns the right altitude of detail for each query — a precise fact, or a distilled principle — in milliseconds, with the evidence trail attached.
Raw knowledge chains, tagged with source and trust from the moment they're ingested.
Bridges built across chains — exact and semantic — walkable back to source.
Novel, merged chains clustered from related inferences into higher-order ideas.
Meta-principles spanning domains — the "why," not just the "what."
The full LoCoMo long-term memory benchmark: 10 long conversations, 1,540 questions. Every system got the same questions, the same answer model (gpt-4o-mini) and the same judge.
| System | Accuracy | Context per question | Cost to save |
|---|---|---|---|
| Tzivia | 50.1% | ~490 tokens | $0 |
| Mem0 (open source) | 44.6% | ~330 tokens | LLM call per message |
| Naive RAG | 35.7% | ~480 tokens | $0 |
| Whole conversation in the prompt | 53.3% | ~26,400 tokens | — |
Tzivia led Mem0 on 7 of 10 conversations. On questions about dates and timing it scored 57.6%, versus 18.7% for the whole conversation. Mem0 here is the open-source mem0ai library run by us, not Mem0's hosted platform; Mem0 publishes higher scores from its own setup. Measured November 2026. Full results and method →
The core divergence-detection mechanism that powers Tzivia's memory generalizes beyond text. In early research, the same engine is being applied to compare a tumor DNA sequence against a matched healthy one, to map where the two structurally diverge. This is a research application, not a validated clinical tool — we're actively seeking research design partners to test it against public genomic data.
Seeking research partners